LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

Home・Lista de Ações・VistaGen Therapeutics Inc

VistaGen Therapeutics Inc

Fechado

4.58 3.39

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

4.46

Máximo

4.59

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+212.2% upside

VistaGen Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

21 de nov. de 2025, 22:42 UTC

Conversa de Mercado

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21 de nov. de 2025, 21:50 UTC

Conversa de Mercado

Ganhos

Tech, Media & Telecom Roundup: Market Talk

21 de nov. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

21 de nov. de 2025, 21:47 UTC

Conversa de Mercado

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21 de nov. de 2025, 21:43 UTC

Conversa de Mercado

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21 de nov. de 2025, 20:18 UTC

Conversa de Mercado

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21 de nov. de 2025, 20:14 UTC

Conversa de Mercado

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21 de nov. de 2025, 19:48 UTC

Conversa de Mercado

Precious Metals Fall for the Week -- Market Talk

21 de nov. de 2025, 19:44 UTC

Ganhos

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21 de nov. de 2025, 19:37 UTC

Conversa de Mercado

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21 de nov. de 2025, 19:27 UTC

Conversa de Mercado

Ganhos

Global Equities Roundup: Market Talk

21 de nov. de 2025, 19:27 UTC

Conversa de Mercado

Ganhos

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21 de nov. de 2025, 19:20 UTC

Conversa de Mercado

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21 de nov. de 2025, 18:44 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21 de nov. de 2025, 18:37 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21 de nov. de 2025, 18:34 UTC

Conversa de Mercado

Ganhos

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21 de nov. de 2025, 18:28 UTC

Ganhos

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21 de nov. de 2025, 18:03 UTC

Conversa de Mercado

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21 de nov. de 2025, 17:24 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

21 de nov. de 2025, 17:24 UTC

Conversa de Mercado

Intuit Seen on Path to Increase Growth -- Market Talk

21 de nov. de 2025, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

21 de nov. de 2025, 17:05 UTC

Conversa de Mercado

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

21 de nov. de 2025, 16:56 UTC

Conversa de Mercado

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

21 de nov. de 2025, 16:47 UTC

Conversa de Mercado

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

21 de nov. de 2025, 16:35 UTC

Aquisições, Fusões, Aquisições de Empresas

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

21 de nov. de 2025, 16:09 UTC

Ganhos

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21 de nov. de 2025, 15:59 UTC

Conversa de Mercado

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

21 de nov. de 2025, 15:59 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 de nov. de 2025, 15:23 UTC

Conversa de Mercado

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

21 de nov. de 2025, 15:17 UTC

Conversa de Mercado

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

Comparação entre Pares

Variação de preço

VistaGen Therapeutics Inc Previsão

Preço-alvo

By TipRanks

212.2% parte superior

Previsão para 12 meses

Média 14.33 USD 212.2%

Máximo 19 USD

Mínimo 12 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para VistaGen Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

Comprar

Manter

Vender

Com base em 4 analistas que deram avaliações de ações para VistaGen Therapeutics Inc - Dist nos últimos 3 meses.

Informação Financeira

Outras ações do setor

LLY

Eli Lilly and Co.

1,058.87

↑ +1.65%

JNJ

Johnson and Johnson

203.92

↑ +0.27%

ABBV

AbbVie Inc

236.16

↑ +2.85%

UNH

UnitedHealth Group Inc

319.35

↑ +2.41%

AZN

AstraZeneca PLC ADR

91.01

↑ +2.64%

VistaGen Therapeutics Inc

Visão Geral

Variação de preço das ações

Recomendações

VistaGen Therapeutics Inc Gráfico

Notícias Relacionadas

Comparação entre Pares

VistaGen Therapeutics Inc Previsão

Preço-alvo

Consenso de Avaliação

Informação Financeira

Outras ações do setor